Aggregate Spending & Regulatory Compliance Solutions for Pharmaceutical, Healthcare, Life Sciences, Biomedical, Medical Device Manufacturers - Porzio Pharmaceutical Services, LLC
PBNLaw
HomeProducts & ServicesAbout UsContact UsSubscriber LoginGoToMeetingBlog

About Us


 

CBI's 5th Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders

November 19, 2008

On Wednesday, November 19, Sarina Rivera spoke at CBI's 5th Annual Defining Appropriate and Effective Interactions with Thought Leaders and Key Opinion Leaders.  Her speech entitled, “Comply with Federal and State Laws and Regulations that Impact KOL Programs,”  looked at the increased scrutiny of pharmaceutical companies’ commercial and promotional efforts.  With the increased scrutiny all departments need to take a more active role in ensuring compliance of their product marketing programs. All who are involved with KOL development and management programs should understand the current legal and regulatory environment to mitigate the risk of noncompliance. In this session, hear an update on the current laws and regulations that impact KOL programs and steps for maintaining compliance. 



Contact Us - Porzio Request more information or call 973.538.1690
 
  << Back
   
©  Porzio Pharmaceutical Services, LLC
PBNLaw Aggregate Spend & Regulatory Compliance Solutions for Pharmaceutical, Healthcare, Life Sciences, Biomedical, and Medical Device Manufacturers - Porzio Pharmaceutical Services, LLC Porzio gov affairs